<DOC>
	<DOCNO>NCT02426645</DOCNO>
	<brief_summary>The aim study investigate association early structural cellular injury microvascular alteration progression septic organ dysfunction accord total SOFA-Score ( ICU-scoring system - Sequential Organ Failure Assessment Score ) . Patients monitor renal ( TIMP-2 , IGFBP7 ) , intestinal biomarkers ( plasma i-FABP ) conjunction kidney muscle vascular bed microvascular perfusion analysis assess contrast-enhanced ultrasonography ( CEUS ) . In parallel , comprehensive analysis patient ' immunological status conduct use establish , on-site immune monitoring panel . The ultimate goal study early identification septic patient develop multiorgan dysfunction may facilitate timely novel intervention future improve outcome .</brief_summary>
	<brief_title>Microcirculatory Alteration Biomarkers : New Approach Early Assessment Septic Multi-organ Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Multiple Organ Failure</mesh_term>
	<criteria>Patients ≥18 year age severe sepsis fulfill follow criterion admission ICU : Peritonitis ( abdominal infection ) perform source control ( either surgically interventionally ) 2 criterion systemic inflammatory response syndrome ( temperature &gt; 38° &lt; 36° ; heart rate &gt; 90 beat per minute ; respiratory rate &gt; 20 breath per minute paCO2 &lt; 32 mmHg ; white blood cell count &gt; 12,000/mm3 , &lt; 4000mm3 &gt; 10 % immature form ) serum lactate level 4mmol/l refractory hypotension mean arterial pressure &lt; 65mmHg systolic blood pressure &lt; 90mmHg fluid challenge 1000ml /30min Absence familial , sociological geographical condition potentially hamper compliance study protocol followup schedule Written inform consent prior study procedure Preexisting renalreplacement therapy preoperative course Preexisting shock Acute coronary syndrome Active hemorrhage Trauma Known allergy ultrasound contrast medium Anemia hemoglobin concentration &lt; 7g/dl Patients able give write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Biomarkers</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Multi organ dysfunction</keyword>
	<keyword>Immunomonitoring</keyword>
	<keyword>CEUS</keyword>
</DOC>